India
USA
UK
Canada
Germany
Australia
UAE
Brazil
South Africa
Malaysia
India
USA
UK
Canada
Germany
Australia
UAE
Brazil
South Africa
Malaysia
Product Overview
Sanjar Pharma manufactures Enoxaparin Sodium Injection 40mg/0.4ml in a prefilled syringe format under WHO-GMP compliant sterile manufacturing conditions. The product is manufactured using validated pharmaceutical processes, controlled production environments, and rigorous quality systems to maintain consistency and reliability.
Enoxaparin Sodium is a Low Molecular Weight Heparin (LMWH) widely used in anticoagulant therapy. The prefilled syringe presentation offers ready-to-use convenience, dosing accuracy, and efficient administration in hospital and clinical settings.
Produced at our sterile injectable manufacturing facility in Gujarat, India, this product is supplied to pharmaceutical distributors, healthcare institutions, procurement organizations, hospital networks, and international pharmaceutical markets.
Technical Specifications
Generic Name
Enoxaparin Sodium
Strength
40mg/0.4ml
Brand Name
SP-NOX
Therapeutic Category
Anticoagulants
Dosage Form
Prefilled Syringe (PFS)
Route of Administration
Subcutaneous Injection
Product Type
Sterile Injectable
Manufacturing Standard
WHO-GMP
Supply Type
Commercial Supply
Contract Manufacturing
Available
Third Party Manufacturing
Available
Regulatory Documentation
Available Upon Request
Storage Condition
As Per Approved Product Specifications
Export Supply
Available
Manufacturing Excellence at Sanjar Pharma
Sanjar Pharma operates a WHO-GMP compliant sterile injectable manufacturing facility supported by advanced production systems, quality assurance programs, and microbiological testing infrastructure.
WHO-GMP Manufacturing Facility
Quality Control Laboratory
Microbiology Laboratory
Quality Assurance Department
Water for Injection (WFI) System
HVAC Cleanroom Infrastructure
Batch Documentation & Traceability
Export-Oriented Manufacturing Operations
Why Choose Sanjar Pharma for Enoxaparin Manufacturing